Category Archives: Pr Newswire

Upstream Bio to Host Webcast to Report Top-Line Results from the Phase 2 VALIANT Trial of Verekitug in Patients with Severe Asthma

– Webcast to be held Wednesday, February 11, 2026, at 8:00 a.m. ET – WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) — Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced it will report top-line results from the Phase 2 VALIANT […]

Blueroot Health Appoints Jay Schwartz CEO as North Castle Backs Next Phase of Practitioner-Focused Growth

MIDDLETOWN, Conn., Feb. 10, 2026 (GLOBE NEWSWIRE) — Blueroot Health, a consumer health company focused on advancing long-term health and well-being for people and the planet, today announced the appointment of Jay Schwartz as chief executive officer. Schwartz succeeds Jane Pemberton, who founded Blueroot Health and built it into a multi-brand, practitioner-trusted platform, leading its […]

Global AI Leader Mark Adams to Keynote Info-Tech LIVE 2026 in Brisbane

As AI moves from experimentation to cultural, economic, and organisational force, CIOs are being challenged to understand not just the technology, but its real-world impact on power, creativity, and decision-making. At Info-Tech LIVE 2026 in Brisbane, March 17 – 18, 2026, global AI leader and advisor Mark Adams will deliver a keynote designed to help IT […]

Ascletis Selects Oral Amylin Receptor Peptide Agonist, ASC36, for Clinical Development

–   Utilizing Ascletis’ Peptide Oral Transport ENhancement Technology (POTENT), ASC36 oral tablets achieved absolute oral bioavailability of 6% to 8% at steady state, in non-human primate (NHP) studies. –   In NHPs, ASC36 oral tablets reduced mean body weight up to 13.2% from baseline after once–daily dosing for 7 days. ASC36 tablets also reduced food intake […]

Daesang Makes First Appearance at Japan’s Largest Food & Distribution Trade Show, SMTS 2026, Signaling Full-Scale Entry into the Japanese Market

– Held February 18–20 in Chiba, Japan, with approximately 2,200 exhibitors and over 70,000 expected visitors – Showcasing flagship products including Jongga Ilpum Kimchi and O’food Gochujang, alongside four tasting menus reflecting local food trends SEOUL, South Korea, Feb. 11, 2026 /PRNewswire/ — Daesang Corporation, a leading Korean food company, announced on February 11 that […]

Quantifind Can Unlock Up to $177.9M in Annual Compliance Efficiency for Tier 1 Banks According to Celent Report

PALO ALTO, Calif., Feb. 11, 2026 /PRNewswire/ — Quantifind, the leader in AI-driven financial crime risk intelligence, today announced the results of a new independent economic study conducted by Celent, which found that Tier 1 banks deploying Quantifind’s Graphyte platform could unlock up to $177.9 million in annual cost savings across Know Your Customer (KYC) […]

Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (Nasdaq: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the pricing of an underwritten offering of 7,868,383 shares of its common stock at a price of $13.98 per share. The gross […]

Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

BOSTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) — Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, after U.S. market close. About Standard BioTools Inc. Standard BioTools Inc. (Nasdaq: LAB), has an established portfolio of essential, standardized next-generation technologies that […]

Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

ALACHUA, Fla. and TAMPA, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) — Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will release financial results for the fourth quarter and full year 2025 on Tuesday, February 24, 2026. Axogen management […]